We now know that only $35.2M was owed and it was entirely repaid in 3Q.
NVS applied $78.2M of Lovenox operating profits to fully recoup its development expenses, which caused MNTA to forego Lovenox profit share in the amount of $78M(0.45) = $35.2M.
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”